|
LOC550112 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.327200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.833600E-01 |
| Normal-vs-Stage2 |
1.219190E-01 |
| Normal-vs-Stage3 |
6.124800E-01 |
| Normal-vs-Stage4 |
1.519620E-01 |
| Stage1-vs-Stage2 |
4.429700E-02 |
| Stage1-vs-Stage3 |
5.424400E-01 |
| Stage1-vs-Stage4 |
6.328200E-02 |
| Stage2-vs-Stage3 |
3.761400E-01 |
| Stage2-vs-Stage4 |
8.204200E-01 |
| Stage3-vs-Stage4 |
3.480400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.200200E-01 |
| Normal-vs-AfricanAmerican |
8.327000E-01 |
| Normal-vs-Asian |
2.704600E-01 |
| Caucasian-vs-AfricanAmerican |
3.393000E-01 |
| Caucasian-vs-Asian |
2.509000E-01 |
| AfricanAmerican-vs-Asian |
1.262430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.170400E-01 |
| Normal-vs-Female |
2.007400E-01 |
| Male-vs-Female |
1.683450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.401200E-01 |
| Normal-vs-Extreme_Weight |
6.849000E-01 |
| Normal-vs-Obese |
4.297600E-01 |
| Normal-vs-Extreme_Obese |
3.515800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.902400E-01 |
| Normal_Weight-vs-Obese |
2.237000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.532400E-01 |
| Extreme_Weight-vs-Obese |
7.034800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.600800E-01 |
| Obese-vs-Extreme_Obese |
7.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.242000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.030570E-01 |
| Normal-vs-Age(61-80Yrs) |
7.449200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.779800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.023600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.819440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.153900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.978360E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.164100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.950400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.582600E-01 |
| Normal-VS-Type2 PRCC |
7.286400E-01 |
| Normal-VS-KIRP CIMP |
2.144100E-02 |
| Normal-VS-Unclassified PRCC |
3.086800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.589600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.994700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.281600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.988900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.772160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.121800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.638400E-01 |
| Normal-vs-N1 |
8.632200E-01 |
| Normal-vs-N2 |
3.215200E-01 |
| N0-vs-N1 |
6.770600E-01 |
| N0-vs-N2 |
3.487200E-01 |
| N1-vs-N2 |
5.819600E-01 |
|
|
